COMMUNIQUÉS West-GlobeNewswire

Generex Biotechnology Announces Update to the Previously Declared 1:1 Stock Dividend
12/08/2019
Filing of up-list application to Nasdaq New Dates Established for 1:1 Shareholder stock dividend New Record Date: August 30, 2019 Pay Date: October 30, 2019 Ex-Date: October 31, 2019 Dividend to be Paid to show [...]
Novadip Biosciences presents poster at 11th annual The Bioprocessing Summit
12/08/2019
Novadip Biosciences presents poster at 11 th annual The Bioprocessing Summit Presentation to focus on manufacturing platform for tissue engineering Mont-Saint Guibert, Belgium, 12 August 2019: Novadip Biosciences (“ [...]
Theratechnologies Files Application to List on NASDAQ
12/08/2019
MONTREAL, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) today announced that it has applied to list its common shares on NASDAQ. “We believe that being listed [...]
Theratechnologies soumet une demande d’inscription au NASDAQ
12/08/2019
MONTRÉAL, 12 août 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Compagnie ») (TSX: TH) a annoncé aujourd’hui avoir soumis une demande d’inscription de ses actions ordinaires au NASDAQ [...]
XOMA’s Royalty Portfolio Expands Significantly
12/08/2019
EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), today announced its portfolio of potential future royalty and milestone payments has significantly increased with the addition of [...]
Entasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
12/08/2019
WALTHAM, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Auxly Announces CEO Succession
12/08/2019
Effective August 27, 2019, Hugo Alves to become Chief Executive Officer (CEO) and Chuck Rifici to serve as Chairman of the Board of Directors VANCOUVER, British Columbia, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis [...]
Onconova Therapeutics and Mission Bio Partner to Advance Precision Oncology Clinical Trials Employing Single-Cell Genomics
12/08/2019
The alliance will leverage Mission Bio’s Tapestri Platform to investigate Onconova’s novel cancer therapy rigosertib, through clinical trials NEWTOWN, Pa. and SOUTH SAN FRANCISCO, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE [...]
Evolus Reports Second Quarter 2019 Financial Results
12/08/2019
Launched Jeuveau ® in the United States on May 15 Jeuveau ® Experience Treatment (J.E.T.) Program Exceeds Expectations Generated $2.3 Million in Jeuveau ® Net Revenue in Q2 2019 NEWPORT BEACH, Calif., Aug. 12, 2019 ( [...]
C-RAD and Mevion Release Integration for Improved Treatment Quality in Proton Therapy
12/08/2019
C-RAD and Mevion Medical Systems â announced today the integration between the C-RAD Catalyst PT™ and the MEVION S250i Proton Therapy System ® . The union of both products supports a seamless workflow with uninterrupted [...]
New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting
12/08/2019
Data demonstrate significant vaccine efficacy against infant pneumonia through the first year of life GAITHERSBURG, Md., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company [...]
Microbix Reports Results for Q3 Fiscal 2019
12/08/2019
Q3 Sales of $3.1 Million and $9.8 Million Year-To-Date TORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, reports results for [...]
Applied Therapeutics Reports Second Quarter 2019 Financial Results
12/08/2019
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet medical need, today [...]
ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP)
12/08/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Kane Biotech Strengthens Team with New Additions in Animal Health and Quality Assurance
12/08/2019
WINNIPEG, Manitoba, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Acacia Pharma Group plc: Notice of Interim Results
12/08/2019
Cambridge, UK and Indianapolis, US – 12 August 2019: Acacia Pharma Group plc (“Acacia Pharma”, the "Company”, the “Group”), (EURONEXT: ACPH), a pharmaceutical company developing and commercialising hospital products for [...]
Aptinyx Reports Second Quarter 2019 Financial Results and Highlights
12/08/2019
Reported that NYX-2925 met primary and secondary endpoints in Phase 2 fibromyalgia study On track to initiate three additional Phase 2 studies in 2H 2019 across pipeline of CNS product candidates Conference call today [...]
Morphic Announces Corporate Highlights and Second Quarter 2019 Financial Results
12/08/2019
- Successful IPO provides more than $100 million in gross proceeds to advance leading oral integrin development pipeline and MInT discovery platform - Company remains on track to file INDs for its two lead programs [...]
BriaCell Appoints Richard J. Berman to Board of Directors
12/08/2019
BERKELEY, Calif., and VANCOUVER, British Columbia, Aug. 12, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]

Pages